GDF15 Circulating Levels Are Associated with Metabolic-Associated Liver Injury and Atherosclerotic Cardiovascular Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26052039 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Josefa Girona und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit on Lipids and Atherosclerosis, University Rovira i Virgili, 43201 Reus, Spain. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Atherosclerosis, Fatty Liver, Cardiovascular Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades.
Abstract (Originalsprache)
There is growing evidence linking growth differentiation factor 15 (GDF15) to both metabolic dysfunction-associated steatotic liver disease (MASLD) and cardiovascular (CV) risk. Nevertheless, the potential relationship between circulating levels of GDF15 and key features of MASLD being predisposed to atherosclerotic CV disease is not fully unveiled. The aim of this study was to deepen into the role of circulating GDF15 levels on metabolic-associated liver injury and atherosclerotic CV disease. We determined the serum GDF15 levels in 156 participants of a metabolic patient-based cohort, and cross-sectionally explored its associations with liver injury and an advanced atherosclerotic lipoprotein profile assessed by nuclear magnetic resonance (1H-NMR). Additionally, we prospectively evaluated the association between GDF15 levels at baseline and incident atherosclerotic CV disease after a 10-year follow-up. GDF15 was related to liver injury and inflammatory hallmarks, and it increased the likelihood for liver steatosis independently of confounding factors. Likewise, GDF15 was positively associated with an atherogenic profile, particularly with the number of very-low-density lipoproteins (VLDL) particles and its cholesterol and triglyceride content, and with an indicator of subclinical atherosclerosis (i.e., carotid intima–media thickness (cIMT)). The baseline serum GDF15 levels were higher in the patients with atherosclerotic CV disease (10.6%) after a 10-year follow-up than in the individuals without CV disease. Altogether, this study provides new insights into the role of GDF15 in both MASLD and CV disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Unit on Lipids and Atherosclerosis, University Rovira i Virgili, 43201 Reus, Spain.
- Vascular Medicine and Metabolism Unit, "Sant Joan de Reus" University Hospital, 43204 Reus, Spain.
- Pere Virgili Health Research Institute (IISPV), 43007 Tarragona, Spain.
- Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Institute of Health Carlos III, 28029 Madrid, Spain.
- Pharmacology Unit, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.
- Institut de Biomedicina de la Universidad de Barcelona (IBUB), University of Barcelona, 08028 Barcelona, Spain.
ORCID-Profile: Josefa Girona, Montse Guardiola, Emma Barroso, Josep Ribalta, Núria Amigó, Xavier Correig, Manuel Vázquez-Carrera, Lluís Masana, Ricardo Rodríguez-Calvo
Förderung
- Centro de Investigación Biomédica en Red
- Instituto de Salud Carlos III
- Ministerio de Ciencia, Innovación y Universidades
- CIBER (Consorcio Centro de Investigación Biomédica en Red)
- Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación
Zitieren
APA
Girona, J., Guardiola, M., Barroso, E., García-Altares, M., Ibarretxe, D., Plana, N., Ribalta, J., Amigó, N., Correig, X., Vázquez-Carrera, M., Masana, L., & Rodríguez-Calvo, R. (2025). GDF15 Circulating Levels Are Associated with Metabolic-Associated Liver Injury and Atherosclerotic Cardiovascular Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26052039
Vancouver
Girona J, Guardiola M, Barroso E, García-Altares M, Ibarretxe D, Plana N, et al. GDF15 Circulating Levels Are Associated with Metabolic-Associated Liver Injury and Atherosclerotic Cardiovascular Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26052039
BibTeX
@article{Girona2025,
author = {Girona, Josefa and Guardiola, Montse and Barroso, Emma and García-Altares, María and Ibarretxe, Daiana and Plana, Núria and Ribalta, Josep and Amigó, Núria and Correig, Xavier and Vázquez-Carrera, Manuel and Masana, Lluís and Rodríguez-Calvo, Ricardo},
title = {GDF15 Circulating Levels Are Associated with Metabolic-Associated Liver Injury and Atherosclerotic Cardiovascular Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26052039}
}
EUVIMED